查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1834044

色素內視鏡藥物市場（按藥物類型、適應症、最終用戶和分銷管道）—全球預測 2025-2032

Chromoendoscopy Agents Market by Agent Type, Indication, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年色素內視鏡藥物市場將成長至 3.7372 億美元，複合年成長率為 7.00%。

主要市場統計數據
基準年2024年 2.1739億美元
預計2025年 2.3252億美元
預測年份：2032年 3.7372億美元
複合年成長率（%） 7.00%

簡潔而權威地介紹了色素內視鏡藥物的臨床作用及其在現代胃腸道診斷和監測中不斷發展的相關性。

色素內視鏡製劑在內視鏡可視化和診斷準確性的交匯點上發揮著至關重要的作用，它能增強對比度，揭示標準白光內造影可能遺漏的細微黏膜異常。染料技術基於局部染色，透過與黏膜表面發生化學相互作用來改善病變的可視化，而虛擬成像技術則應用後處理演算法和窄頻頻譜濾波，無需使用外源染料即可增強血管和組織模式。這些技術共同為臨床醫生在篩檢、監測和診斷過程中提供支援。

不斷發展的臨床實踐越來越重視胃腸道腫瘤的早期發現和精準診斷。因此，執業醫師和醫療保健系統在選擇色素內視鏡檢查方法時，擴大考慮診斷率、操作流程整合、訓練要求和病人安全之間的平衡。內視鏡硬體、影像處理軟體和輔助分析的進步也拓展了染料和虛擬成像方法的實用性。因此，色素內視鏡檢查試劑不再只是內視鏡檢查的輔助手段，而是擴大被納入到注重可操作性觀察和後續臨床決策的綜合診斷策略中。

技術整合、人工智慧的興起以及不斷變化的臨床需求如何將色素內視鏡藥物轉變為綜合診斷途徑的推動者

科技的融合、日趨成熟的監管環境以及臨床重點的轉變，正在共同重塑色素內視鏡的格局。隨著內視鏡製造商將先進的光源和影像後處理技術直接整合到其平台中，虛擬成像模式（包括靈活的頻譜成像色彩增強、i-Scan 和窄帶成像）正在從小眾輔助轉變為主流工具。同時，染料配方、應用技術和安全性的改進，重新激發了人們對靶向染色的興趣，尤其是在虛擬對比度不足的扁平或細微病變方面。

除了硬體和化學方面的挑戰之外，人工智慧和機器學習驅動的病變檢測技術的出現，透過實現即時影像解讀和標準化病變表徵，正在擴大色素內視鏡的影響力。同時，報銷框架的變化和對基於價值的醫療服務的需求，正在推動醫療保健系統尋求能夠透過更早的發現和更少的漏診病變來顯著降低下游成本的檢測方法。培訓和認證工作也在不斷調整，基於模擬的教育和能力評估正在加速操作人員的熟練程度。總而言之，這些轉變標誌著一項獨立技術正在成熟，並朝著優先考慮靈敏度、工作流程效率和可重複臨床結果的整合診斷途徑邁進。

評估累積關稅調整將如何重塑整個色素內視鏡藥物生態系統的採購、供應鏈彈性和模式偏好

貿易主管機關實施的累積關稅政策變更給進口影像組件和化學品的採購、製造和分銷網路帶來了新的壓力。進口關稅的增加增加了某些染料前驅物、專用試劑和高價值光學組件的到岸成本，迫使採購商和經銷商重新評估其供應商選擇和總到岸成本計算。因此，最終用戶面臨採購週期的潛在調整，他們正在評估長期合約和在地採購方案，以降低未來貿易政策波動帶來的風險。

為了應對這項挑戰，製造商和經銷商正在多元化其供應鏈，在低關稅地區尋找替代供應商，並考慮將高成本或具有戰略重要性的零件部分外包。這些策略轉變降低了前置作業時間風險，並加強了品質和合規性控制。此外，關稅帶來的成本壓力可能會加速虛擬內視鏡技術的採用，該技術更依賴軟體和光學元件，而非耗材染料，從而在成本敏感的環境中改變購買偏好。最終，關稅、外匯波動和供應鏈重組的綜合影響正在塑造整個色素內視鏡生態系統的籌資策略和商業模式。

將藥品類型、適應症、最終用戶和分銷管道聯繫起來的分段分析揭示了差異化的採用促進因素和採購動態

基於細分的洞察揭示了不同藥物類型、適應症、最終用戶和分銷管道的需求促進因素和採用動態。同時，諸如軟性頻譜成像色彩增強、i-Scan 和窄帶成像等虛擬技術正日益成為整合式非耗材替代方案，從而減少對每次手術耗材的依賴。這些設備差異體現在在內視鏡設備資產規劃中，並影響臨床醫師的訓練重點，以最佳化不同病例組合中的病變檢測。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 擴大應用 NBI 和 i-scan 等虛擬色素內視鏡技術，以提高大腸直腸癌篩檢的病變檢測率
  • 人工智慧影像分析平台與色素內視鏡結合，可即時表徵息肉
  • 胃腸內視鏡檢查中針對發育不良組織的新型螢光分子探針的開發
  • 監管部門核准擴大創新造影劑在胃腸道病變可視化的適應症
  • 越來越多的臨床研究證明色素內視鏡檢查在降低大腸直腸癌發生率方面具有成本效益
  • 加大對共聚焦雷射內視鏡與色素內視鏡藥物結合用於精準診斷的研究投入
  • 大腸直腸癌篩檢計畫擴大色素內視鏡在新興市場的使用
  • 更新的國際內視鏡指南建議在高風險患者群體中常規使用色素內視鏡檢查
  • 造影劑造影與內視鏡技術供應商之間的策略聯盟改變了競爭格局
  • 專注於培訓計劃和人工智慧驅動的模擬工具，以提高內視鏡醫師對色素內視鏡技術的熟練程度

第6章 2025年美國關稅的累積影響

第7章：人工智慧2025的累積影響

8. 色素內視鏡藥物市場（依藥物類型）

  • 染料基
    • 甲酚紫
    • 靛藍胭脂紅
    • 亞甲基藍
  • 虛擬的
    • 靈活的頻譜色彩增強
    • i-Scan
    • 窄頻成像

9.依適應症分類的色素內視鏡藥物市場

  • 結腸癌檢測
  • 食道癌檢測
  • 胃癌檢測
  • 發炎性腸道疾病監測

第 10 章色素內視鏡藥物市場（依最終使用者）

  • 門診手術中心
  • 診所
  • 醫院

第 11 章：按分銷管道分類的色素內視鏡藥物市場

  • 醫院藥房
  • 網路藥局
  • 零售藥局

第 12 章 按地區分類的色素內視鏡藥物市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章：按群體分類的色素內視鏡藥物市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章。 色素內視鏡藥物市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Avantor, Inc.
    • Cardinal Health, Inc.
    • Becton Dickinson and Company
    • Olympus Corporation
    • FUJIFILM Holdings Corporation
    • HOYA Corporation
    • Boston Scientific Corporation
    • Medtronic plc
Product Code: MRR-433AB1DC2933

The Chromoendoscopy Agents Market is projected to grow by USD 373.72 million at a CAGR of 7.00% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 217.39 million
Estimated Year [2025] USD 232.52 million
Forecast Year [2032] USD 373.72 million
CAGR (%) 7.00%

A concise and authoritative introduction to chromoendoscopy agents, their clinical role, and evolving relevance in contemporary gastrointestinal diagnostics and surveillance

Chromoendoscopy agents occupy a pivotal role at the intersection of endoscopic visualization and diagnostic accuracy, enhancing contrast to reveal subtle mucosal abnormalities that standard white-light endoscopy may miss. Dye-based techniques, historically rooted in topical staining practices, work by chemically interacting with the mucosal surface to improve lesion delineation, whereas virtual contrast technologies apply post-processing algorithms and narrowband spectral filtering to emphasize vascular and tissue patterns without exogenous dyes. Together these modalities support clinicians across screening, surveillance, and diagnostic pathways.

The evolving clinical landscape places an increasing premium on early detection and precision characterization of gastrointestinal neoplasia. As a result, practitioners and health systems are balancing considerations of diagnostic yield, procedural workflow integration, training requirements, and patient safety when selecting chromoendoscopy approaches. Regulatory oversight and evolving clinical guidelines continue to shape adoption patterns, while advances in endoscope hardware, imaging software, and adjunctive analytics are expanding the practical utility of both dye-based and virtual imaging methods. Consequently, chromoendoscopy agents are not merely adjuncts to endoscopy but are becoming embedded in comprehensive diagnostic strategies that emphasize actionable findings and downstream clinical decision-making.

How technological integration, AI augmentation, and shifting clinical imperatives are transforming chromoendoscopy agents into integrated diagnostic pathway enablers

Technological convergence, regulatory maturation, and changing clinical priorities are jointly redefining the chromoendoscopy landscape. Virtual imaging methods such as flexible spectral imaging color enhancement, I-Scan, and narrow band imaging are moving from niche adjuncts to mainstream tools as endoscope manufacturers integrate advanced light sources and image post-processing directly into platforms. Simultaneously, improvements in dye formulations, application techniques, and safety profiles have rejuvenated interest in targeted staining where virtual contrast may be insufficient, particularly for flat or subtle lesions.

Beyond hardware and chemistry, the emergence of artificial intelligence and machine-learning-driven lesion detection is amplifying the impact of chromoendoscopy by enabling real-time image interpretation and standardized lesion characterization. In parallel, shifting reimbursement frameworks and value-based care imperatives are prompting health systems to seek modalities that demonstrably reduce downstream costs through earlier detection and fewer missed lesions. Training and credentialing initiatives are adapting as well, with simulation-based education and competency assessments accelerating operator proficiency. Taken together, these shifts signal a maturation from isolated techniques to integrated diagnostic pathways that prioritize sensitivity, workflow efficiency, and reproducible clinical outcomes.

Assessing how cumulative tariff adjustments reshape procurement, supply chain resilience, and modality preferences across the chromoendoscopy agents ecosystem

The cumulative tariff policy changes enacted by trade authorities have introduced new pressures across procurement, manufacturing, and distribution networks for imported imaging components and chemical agents. Increased import levies raise landed costs for certain dye precursors, specialty reagents, and high-value optical components, prompting purchasers and distributors to reassess supplier selection and total landed cost calculations. As a result, end users face potential adjustments in procurement cycles, where longer-term contracts and local sourcing options are evaluated to mitigate exposure to future trade policy volatility.

In response, manufacturers and distributors are diversifying supply chains, seeking alternate suppliers in low-tariff jurisdictions, and exploring partial onshoring for high-cost or strategically sensitive components. These strategic shifts reduce lead time risk and enhance control over quality and compliance, but they also require capital investment and regulatory alignment for relocated production. Moreover, tariff-driven cost pressures may accelerate the adoption of virtual chromoendoscopy technologies that depend more on software and optics than on consumable dyes, altering purchasing preferences in cost-sensitive settings. Ultimately, the combined effects of tariffs, currency fluctuations, and supply chain realignment are shaping procurement strategies and commercial models throughout the chromoendoscopy ecosystem.

Segment-specific analysis that connects agent modality, clinical indication, care setting, and distribution channel to reveal differentiated adoption drivers and procurement dynamics

Segmentation-based insights reveal distinct demand drivers and adoption dynamics across agent type, clinical indication, end user, and distribution channel. Based on agent type, the market divides into dye based and virtual approaches; within dye based options practitioners still rely on cresyl violet, indigo carmine, and methylene blue to enhance mucosal pattern recognition in specific anatomic contexts, while virtual technologies such as flexible spectral imaging color enhancement, I-Scan, and narrow band imaging increasingly serve as integrated, nonconsumable alternatives that reduce per-procedure consumable dependency. These modality distinctions inform capital planning for endoscopy units and influence training priorities for clinicians seeking to optimize lesion detection under diverse case mixes.

Based on indication, demand varies across colorectal cancer detection, esophageal cancer detection, gastric cancer detection, and inflammatory bowel disease surveillance, each presenting unique lesion morphologies and clinical workflow requirements that favor different chromoendoscopy strategies. Based on end user, adoption differs among ambulatory surgery centers, clinics, and hospitals, with ambulatory settings placing a premium on throughput and cost-efficiency while hospitals emphasize complex diagnostic capability and multidisciplinary integration. Based on distribution channel, supply dynamics range from hospital pharmacies maintaining institutional inventories to online pharmacies offering procurement flexibility and retail pharmacies serving outpatient needs; these channels influence inventory turnover, purchasing cadence, and access in both urban and resource-constrained environments. Synthesizing these segmentation lenses highlights where clinical need, operational constraints, and procurement pathways intersect to shape technology and reagent prioritization across providers.

Regional dynamics and practical implications for clinical adoption, supply chain strategy, and evidence generation across major global healthcare regions

Regional dynamics significantly influence clinical practice patterns, regulatory timelines, and supply chain strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, clinical guidelines and reimbursement frameworks often support early adoption of both advanced imaging platforms and established dye techniques, with academic centers driving innovation and serving as early validation sites for new protocols. In contrast, Europe, Middle East & Africa present a heterogeneous regulatory landscape where country-level reimbursement decisions, varied training infrastructures, and regional procurement models affect speed of uptake; collaborative regional registries and guideline harmonization efforts play a decisive role in enabling broader adoption.

The Asia-Pacific region is characterized by rapid technology adoption in certain high-volume urban centers alongside constrained access in rural areas; strong manufacturing ecosystems in the region also influence global supply chains for optical components and reagent production. Across regions, clinical outcomes data, local guideline endorsements, and training capacity shape preference for dye-based versus virtual approaches. Consequently, market participants must navigate divergent regulatory pathways, tailor go-to-market approaches to local reimbursement realities, and invest in region-specific evidence generation to accelerate clinician acceptance and payer recognition.

Insightful competitive overview highlighting how platform integration, reagent specialization, clinical evidence, and partnerships define success across the chromoendoscopy ecosystem

Competitive positioning in the chromoendoscopy agents space is shaped less by a single monopolistic player and more by a constellation of specialized imaging manufacturers, diagnostic reagent suppliers, and regional distributors. Leading market participants differentiate through platform-level integration that pairs advanced optics and software with clinical support services, while reagent specialists focus on formulation safety, ease of application, and compatibility with procedural workflows. Distribution and commercialization strategies emphasize channel partnerships, value-added service agreements, and clinician training programs to drive sustained adoption.

Strategic behaviors include pursuing regulatory clearances that open new indications and reimbursement pathways, establishing collaborative clinical studies to demonstrate comparative clinical utility, and forming alliances with endoscopy service providers to embed products into standardized care protocols. In addition, companies that invest in interoperability, robust post-market surveillance, and outcome-driven evidence generation strengthen payer and hospital-level value propositions. Smaller innovators often play catalytic roles by developing niche chemistries or software features that larger firms subsequently integrate through licensing or acquisition, underscoring an ecosystem where partnership and targeted M&A activity remain important routes to scale and differentiation.

Practical and prioritized strategic actions for industry leaders to enhance product differentiation, supply resilience, evidence generation, and payer engagement

Industry leaders should adopt a multi-pronged strategy that aligns product development, evidence generation, and commercial execution with evolving clinical priorities and procurement realities. First, prioritize investment in virtual imaging enhancements and AI-enabled lesion detection while maintaining a pipeline of safer, easier-to-apply dye formulations for indications where staining remains clinically superior. Second, strengthen supply chain resilience through multi-sourcing, regional manufacturing partnerships, and inventory strategies that mitigate tariff and logistics volatility, thereby protecting margin and ensuring consistent clinical supply.

Third, accelerate real-world evidence programs and pragmatic clinical studies that quantify diagnostic yield improvements, procedure time impacts, and downstream clinical benefits, enabling stronger reimbursement conversations and hospital adoption. Fourth, tailor commercial models to care settings: offer streamlined procurement and cost-effective bundles for ambulatory surgery centers, while providing integrated training, credentialing support, and clinical partnership programs for hospitals. Finally, engage proactively with regulators and payers to clarify evidentiary expectations and to explore value-based contracting models that reward demonstrable improvements in diagnostic accuracy and patient outcomes.

Clear explanation of the mixed-methods research approach combining primary expert interviews, secondary literature synthesis, and iterative triangulation for robust findings

The research methodology underpinning this analysis combined structured primary engagements with clinicians, procurement leaders, and industry executives, rigorous secondary literature synthesis of peer-reviewed clinical studies and procedural guidelines, and triangulation across expert input to validate themes and strategic implications. Primary research included qualitative interviews with end users across ambulatory, clinic, and hospital settings, in addition to discussions with regulatory specialists and supply chain managers to capture the operational implications of tariffs and distribution models.

Secondary sources focused on recent clinical trials, consensus statements, and device regulatory frameworks to ensure accuracy in describing modality capabilities and safety considerations. Data synthesis emphasized thematic convergence and discrepancy resolution through iterative expert review. Where limitations exist, they relate to the pace of technological innovation and the variable timing of regional regulatory decisions, both of which can alter adoption trajectories; to mitigate this, the methodology incorporates an update cadence and recommends supplemental targeted studies to maintain relevance for stakeholders planning near-term investments or clinical program rollouts.

Concluding synthesis that emphasizes complementary modality strategies, evidence needs, training priorities, and regional considerations for impactful chromoendoscopy adoption

Chromoendoscopy agents are positioned at an important inflection point where technological advances, clinical demand for improved diagnostic accuracy, and supply chain realignment converge. The combined progress in virtual imaging and AI-assisted interpretation enhances noninvasive diagnostic capabilities, while targeted dye-based approaches retain critical value for specific lesion types and clinical scenarios. Consequently, stakeholders must adopt balanced strategies that recognize modality complementarities rather than viewing one approach as universally superior.

Looking forward, sustained adoption will hinge on convincing real-world evidence that links chromoendoscopy-enabled detection improvements to clear clinical and economic outcomes, coupled with pragmatic commercial models that address procurement complexity and tariff-driven cost pressures. Training and credentialing efforts will remain central to ensuring reproducible performance across operators, and regional strategies must account for divergent regulatory and reimbursement environments. Overall, the combination of clinical need, technological innovation, and strategic commercial execution will determine the pace and breadth of chromoendoscopy integration into routine gastrointestinal care pathways.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of virtual chromoendoscopy technologies such as NBI and i-scan to enhance lesion detection in colorectal screening
  • 5.2. Emergence of AI-enabled image analysis platforms integrated with chromoendoscopy for real-time polyp characterization
  • 5.3. Development of novel fluorescent molecular probes targeting dysplastic tissue during gastrointestinal endoscopy
  • 5.4. Regulatory approvals expanding indications for innovative contrast dyes in gastrointestinal lesion visualization
  • 5.5. Growing number of clinical studies demonstrating cost-effectiveness of chromoendoscopy in reducing colorectal cancer rates
  • 5.6. Rising investments in research combining chromoendoscopy agents with confocal laser endomicroscopy for precision diagnosis
  • 5.7. Expansion of chromoendoscopy agent usage in emerging markets driven by colorectal cancer screening initiatives
  • 5.8. Updates to international endoscopy guidelines recommending routine use of chromoendoscopy for high-risk patient populations
  • 5.9. Competitive landscape shifts with strategic partnerships between dye manufacturers and endoscope technology providers
  • 5.10. Focus on training programs and AI-driven simulation tools to improve endoscopist proficiency in chromoendoscopy techniques

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Chromoendoscopy Agents Market, by Agent Type

  • 8.1. Dye Based
    • 8.1.1. Cresyl Violet
    • 8.1.2. Indigo Carmine
    • 8.1.3. Methylene Blue
  • 8.2. Virtual
    • 8.2.1. Flexible Spectral Imaging Color Enhancement
    • 8.2.2. I-Scan
    • 8.2.3. Narrow Band Imaging

9. Chromoendoscopy Agents Market, by Indication

  • 9.1. Colorectal Cancer Detection
  • 9.2. Esophageal Cancer Detection
  • 9.3. Gastric Cancer Detection
  • 9.4. Inflammatory Bowel Disease Surveillance

10. Chromoendoscopy Agents Market, by End User

  • 10.1. Ambulatory Surgery Center
  • 10.2. Clinic
  • 10.3. Hospital

11. Chromoendoscopy Agents Market, by Distribution Channel

  • 11.1. Hospital Pharmacy
  • 11.2. Online Pharmacy
  • 11.3. Retail Pharmacy

12. Chromoendoscopy Agents Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Chromoendoscopy Agents Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Chromoendoscopy Agents Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Thermo Fisher Scientific Inc.
    • 15.3.2. Merck KGaA
    • 15.3.3. Avantor, Inc.
    • 15.3.4. Cardinal Health, Inc.
    • 15.3.5. Becton Dickinson and Company
    • 15.3.6. Olympus Corporation
    • 15.3.7. FUJIFILM Holdings Corporation
    • 15.3.8. HOYA Corporation
    • 15.3.9. Boston Scientific Corporation
    • 15.3.10. Medtronic plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CHROMOENDOSCOPY AGENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CHROMOENDOSCOPY AGENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CHROMOENDOSCOPY AGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CRESYL VIOLET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CRESYL VIOLET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CRESYL VIOLET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CRESYL VIOLET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CRESYL VIOLET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CRESYL VIOLET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDIGO CARMINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDIGO CARMINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDIGO CARMINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDIGO CARMINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDIGO CARMINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDIGO CARMINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY METHYLENE BLUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY METHYLENE BLUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY METHYLENE BLUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY METHYLENE BLUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY METHYLENE BLUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY METHYLENE BLUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FLEXIBLE SPECTRAL IMAGING COLOR ENHANCEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FLEXIBLE SPECTRAL IMAGING COLOR ENHANCEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FLEXIBLE SPECTRAL IMAGING COLOR ENHANCEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FLEXIBLE SPECTRAL IMAGING COLOR ENHANCEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FLEXIBLE SPECTRAL IMAGING COLOR ENHANCEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY FLEXIBLE SPECTRAL IMAGING COLOR ENHANCEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY I-SCAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY I-SCAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY I-SCAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY I-SCAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY I-SCAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY I-SCAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY NARROW BAND IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY NARROW BAND IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY NARROW BAND IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY NARROW BAND IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY NARROW BAND IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY NARROW BAND IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COLORECTAL CANCER DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COLORECTAL CANCER DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COLORECTAL CANCER DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COLORECTAL CANCER DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COLORECTAL CANCER DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COLORECTAL CANCER DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ESOPHAGEAL CANCER DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ESOPHAGEAL CANCER DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ESOPHAGEAL CANCER DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ESOPHAGEAL CANCER DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ESOPHAGEAL CANCER DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ESOPHAGEAL CANCER DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GASTRIC CANCER DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GASTRIC CANCER DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GASTRIC CANCER DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GASTRIC CANCER DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GASTRIC CANCER DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GASTRIC CANCER DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE SURVEILLANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE SURVEILLANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE SURVEILLANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE SURVEILLANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE SURVEILLANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CLINIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CLINIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CLINIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY CLINIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 260. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 261. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 262. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 263. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 264. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 265. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 268. GCC CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 283. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 288. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 291. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 292. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 293. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 297. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 302. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 303. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 304. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 305. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 306. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 307. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. G7 CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 311. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY AGENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2018-2024 (USD MILLION)
  • TABLE 316. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DYE BASED, 2025-2032 (USD MILLION)
  • TABLE 317. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2018-2024 (USD MILLION)
  • TABLE 318. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY VIRTUAL, 2025-2032 (USD MILLION)
  • TABLE 319. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 320. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 321. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 324. NATO CHROMOENDOSCOPY AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 325. GLOBAL CHROMOENDOSCOPY AGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)